Related Experiment Video
Updated: Jan 12, 2026

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
Adjunctive smart ring monitoring during digital cognitive behavioral therapy for insomnia
Daa Un Moon1,2, Yujin Lee3,4, Alva Lütt5,6,7,8
1Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Zu Berlin, Berlin, Germany. daaunmoon@gmail.com.
Abstract:
Digital cognitive behavioral therapy for insomnia (dCBT-I) has emerged as a treatment for chronic insomnia. Smart rings provide objective, wearable-derived sleep data that may complement subjective sleep diaries, but their role in monitoring treatment response remains unclear. This study evaluated the clinical effectiveness of dCBT-I with smart rings and compared subjective and wearable-derived sleep measures. In this single-arm study, individuals with insomnia completed a dCBT-I program, alongside daily sleep monitoring using a smart ring and sleep diary. Changes in clinical symptoms were analyzed, and sleep parameters were compared across the two tools. Twenty-eight participants completed the study, with significant improvements in insomnia severity (ΔISI = - 6.16, p = .011) and anxiety symptoms (ΔGAD-7 = - 2.38, p = .038). Adherence to the smart ring was higher than to sleep diaries (52.5 vs. 44.5 days, p = .002). Sleep diaries showed significant improvements in sleep parameters, which were not reflected in smart ring data. Systematic differences were observed between data sources. dCBT-I combined with smart rings improved clinical symptoms. However, smart rings did not reflect sleep improvements seen in diaries, limiting their clinical use as a standalone monitoring tool for insomnia management.Clinical trial registration Study of Efficacy of Digital Cognitive BehavioralTherapy with Wearable Device for Insomnia. Registered on 24/03/2024, ClinicalTrials.gov (NCT06339853), https://clinicaltrials.gov/study/NCT06339853 .
Related Concept Videos
Management of Insomnia
REM Sleep Behavior Disorder
RBD is significantly associated with...
Insomnia
Multiple factors contribute...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleep Apnea
The condition is more prevalent among...

